Breaking: Dentsply International Inc (NASDAQ:XRAY) Stock Sentiment Worsens

November 28, 2016 - By Darrin Black   ·   0 Comments

Breaking: Dentsply International Inc (NASDAQ:XRAY) Stock Sentiment  Worsens

Sentiment for Dentsply International Inc (NASDAQ:XRAY)

Dentsply International Inc (NASDAQ:XRAY) institutional sentiment increased to 0.45 in 2016 Q2. Its up 0.19, from 0.26 in 2016Q1. The ratio has increased, as 5 investment professionals started new or increased holdings, while 19 cut down and sold equity positions in Dentsply International Inc. The investment professionals in our partner’s database now hold: 2.10 million shares, down from 2.88 million shares in 2016Q1. Also, the number of investment professionals holding Dentsply International Inc in their top 10 holdings was flat from 0 to 0 for the same number . Sold All: 12 Reduced: 7 Increased: 2 New Position: 3.

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, makes and markets a range of consumable dental products for the professional dental market. The company has a market cap of $14.00 billion. The Firm also makes and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. It has a 31.01 P/E ratio. The Company’s divisions include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses.

About 978,689 shares traded hands. DENTSPLY SIRONA Inc (NASDAQ:XRAY) has declined 0.59% since April 25, 2016 and is downtrending. It has underperformed by 6.60% the S&P500.

Analysts await DENTSPLY SIRONA Inc (NASDAQ:XRAY) to report earnings on February, 10. They expect $0.67 EPS, up 3.08% or $0.02 from last year’s $0.65 per share. XRAY’s profit will be $155.30M for 22.54 P/E if the $0.67 EPS becomes a reality. After $0.66 actual EPS reported by DENTSPLY SIRONA Inc for the previous quarter, Wall Street now forecasts 1.52% EPS growth.

According to Zacks Investment Research, “DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company’s products include dental prosthetics, endodontic instruments, dental sealants, ultrasonic scalers, dental x-ray equipment and intraoral cameras. DENTSPLY SIRONA Inc., formerly known as DENTSPLY International Inc., is based in United States.”

Alleghany Corp De holds 3.81% of its portfolio in DENTSPLY SIRONA Inc for 1.60 million shares. De Burlo Group Inc owns 132,050 shares or 1.98% of their US portfolio. Moreover, Cardinal Capital Management has 1.69% invested in the company for 67,070 shares. The New York-based Tirschwell & Loewy Inc has invested 1.67% in the stock. Palo Capital Inc., a California-based fund reported 40,422 shares.#img1#

Insider Transactions: Since January 1, 0001, the stock had 0 insider buys, and 5 sales for $7.84 million net activity.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) Ratings Coverage

Ratings analysis reveals 67% of Dentsply International’s analysts are positive. Out of 12 Wall Street analysts rating Dentsply International, 8 give it “Buy”, 0 “Sell” rating, while 4 recommend “Hold”. The lowest target is $60 while the high is $70. The stock’s average target of $63.75 is 5.56% above today’s ($60.39) share price. XRAY was included in 18 notes of analysts from August 3, 2015. Robert W. Baird upgraded it to “Outperform” rating and $61.0 target price in Wednesday, September 16 report. Piper Jaffray initiated the stock with “Overweight” rating in Monday, June 13 report. Barrington Research upgraded the shares of XRAY in a report on Wednesday, September 16 to “Outperform” rating. William Blair upgraded the shares of XRAY in a report on Monday, September 21 to “Outperform” rating. The rating was maintained by Barrington Research on Friday, May 13 with “Outperform”. The firm has “Hold” rating by Zacks given on Thursday, September 3. The stock of DENTSPLY SIRONA Inc (NASDAQ:XRAY) has “Neutral” rating given on Thursday, February 25 by UBS. The stock of DENTSPLY SIRONA Inc (NASDAQ:XRAY) has “Overweight” rating given on Tuesday, November 1 by Morgan Stanley. The firm has “Equal-Weight” rating given on Thursday, March 24 by Morgan Stanley. The stock of DENTSPLY SIRONA Inc (NASDAQ:XRAY) earned “Neutral” rating by JP Morgan on Thursday, September 22.

XRAY Company Profile

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., incorporated on February 15, 1983, designs, develops, makes and markets a range of consumable dental products for the professional dental market. The Firm also makes and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s divisions include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Firm distributes its products in over 120 countries.

More recent DENTSPLY SIRONA Inc (NASDAQ:XRAY) news were published by: Wsj.com which released: “Dentsply Sirona to Buy MIS Implants for $375 Million” on June 27, 2016. Also Seekingalpha.com published the news titled: “Dentsply Sirona’s (XRAY) CEO Jeffrey Slovin on Q2 2016 Results – Earnings Call …” on August 05, 2016. Nasdaq.com‘s news article titled: “DENTSPLY SIRONA is Now Oversold (XRAY)” with publication date: October 26, 2016 was also an interesting one.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Darrin Black

Tags: , ,


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>